Home
Biogen

Biogen Market Share Analysis for August 2026

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Industry: N/A

Domainbiogen.ca

Year Founded1978

Employees5001 - 10000

Annual Revenue> $1B

Biogen

Biogen (including company regionals)

biogen.ca

See more website traffic and engagement information

Biogen Revenue up to August 2026 is > 1B

revenue generated by Biogen top domains

Biogen top domains revenue over 3 years

Revenue for Biogen top domains

biogen.ca> 1B

See more with Sales Intelligence

Biogen Stock price in August 2026

Biogen stock is traded under the ticker #BIIB. Below you can review Biogen stock performance in the past 12 months up to August 2026

Total visits to Biogen's top domains

Understand Biogen market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biogen.ca6.4K

See more with Sales Intelligence

Avg. visit duration in Biogen's top domains

Analyze Biogen engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biogen.ca00:00:22

See more with Sales Intelligence

Avg. pageviews on Biogen's top domains

See how Biogen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biogen.ca1.71

See more with Sales Intelligence

Biogen top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Biogen

These are the website technologies, by industry, used by Biogen top domains

Conversion & Analytics (5)

Google Analytics

Advertising (3)

DoubleClick

Audio Video Media (2)

VideoJS

Marketing (2)

Google Marketing Platform

More Technologies

7

See all

News & Signals from Biogen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiogen Canada Inc launches BYOOVIZ in the United States.As Quinn & Morris, PC previously reported, Biogen launched BYOOVIZ in the United States on June 2, 2022.

NewsBiogen Canada Inc launches Samsung Bioepis-developed Byooviz version of Lucentis in Canada.Biogen has launched the Samsung Bioepis-developed Byooviz version of Lucentis in Canada, marking the first and only ranibizumab biosimilar to be approved and introduced in the market.

NewsBiogen Canada Inc recognized as Best WorkplaceTM for Giving Back and Hybrid Work.As a company that founds its culture on principles of equity, diversity and inclusion, Biogen Canada is proud to have been named a Best Workplace™ for Giving Back and Hybrid Work.